Cancer, a major world public health problem, is associated with chemotherapy treatments
whose administration leads to secondary concerns, such as oral mucositis (OM). The OM …

Background Chitosan is a cheap, accessible, nontoxic, biocompatible, and biodegradable
compound. Also, this polysaccharide possesses antibacterial and anti-inflammatory …

Photobiomodulation therapy (PBMT) is widely used in oncology settings, but lack of
assessment standardization is the main barrier to optimization of clinical protocols. This …

The oral cavity is constantly exposed to contact with an external environment. Pathogens
can easily access and colonize it, causing a number of medical conditions that are usually …

Aim This retrospective cohort study aimed to evaluate the association between body weight
and oral cGVHD (chronic graft versus host disease). Methods Patients with oral cGVHD …

Background Oral mucositis (OM), an acute inflammation of the oral cavity, is a common
complication in patients undergoing invasive myeloblastic chemotherapy or radiation …

Background Concurrent chemoradiotherapy (CCRT)-induced oral mucositis (OM) causes
oral pain, malnutrition, and impaired quality of life in patients with head and neck cancer …

Background Oral mucositis (OM) is considered one of the most common side effects of
patients undergoing cancer therapy. OM prevention plays a crucial role in the effectiveness …

Oral mucositis (OM) is a common side effect of cancer treatments characterized by disruption
of the oral mucosa integrity, inflammation, and pain. The treatment strategies to prevent and …

Objective Anxiety and depression are frequent conditions among individuals undergoing
antineoplastic therapy, but their relationship with oral mucositis is unclear. This systematic …